Q1 2016 EPS Estimates for Gilead Sciences, Inc. (GILD) Lifted by Leerink Partner


Gilead Sciences, Inc. - Analysts at Leerink Partner lifted their Q1 2016 earnings per share estimates for Gilead Sciences in a note issued to investors on Thursday, according to Zacks Investment Research . Leerink Partner analyst G. Porges now expects that the brokerage will earn $3.29 per share for the quarter, up from their prior forecast of $3.08.



from Biotech News